MTUM vs XBI
iShares MSCI USA Momentum Factor ETF vs SPDR S&P Biotech ETF
- • MTUM has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • MTUM pays a higher dividend yield (0.54%).
Side-by-side metrics
| Metric | MTUM | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.54% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $29.05B | $10.73B |
YTD return | 26.03% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.24 | 1.10 |
P/E ratio | 33.39 | — |
Last price | $324.21 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
MTUM top holdings
| MU | Micron Technology Inc | 7.19% |
| INTC | Intel Corp | 5.49% |
| AMD | Advanced Micro Devices Inc | 5.44% |
| CAT | Caterpillar Inc | 4.17% |
| AVGO | Broadcom Inc | 4.00% |
| LRCX | Lam Research Corp | 4.00% |
| AMAT | Applied Materials Inc | 3.86% |
| GEV | GE Vernova Inc | 3.18% |
| JNJ | Johnson & Johnson | 3.06% |
| XOM | Exxon Mobil Corp | 2.89% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About MTUM
MTUM (iShares MSCI USA Momentum Factor ETF) is US large-caps with momentum tilt. Managed by iShares, the fund carries $29.0B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.54%. Its largest holding is Micron Technology Inc (MU), which represents 7.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.